Luke Eivers

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation.
  2023 L1 83/100

1 assessed by us (1 reproduced) · 15 not yet assessed — every PubMed paper on record, linked below.

• Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression ↗

  Gastroenterology · 2026 · PMID 42102979
  not yet assessed
• Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolution ↗

  Immunity · 2025 · PMID 40280129
  not yet assessed
• Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2025
  not yet assessed
• Single-cell multiomics of human thrombosis reveals immunothrombolytic monocyte-neutrophil interactions and hypoxia-driven thrombus resolution ↗

  European Heart Journal · 2025
  not yet assessed
• Procoagulant platelet activation promotes venous thrombosis ↗

  Blood · 2024 · PMID 39440970
  not yet assessed
• Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes ↗

  Nature Medicine · 2024 · PMID 38773340
  not yet assessed
• Peripheral priming induces plastic transcriptomic and proteomic responses in circulating neutrophils required for pathogen containment ↗

  Science Advances · 2024 · PMID 38517968
  not yet assessed
• Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2024
  not yet assessed
• Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation

  Immunity · 2023 · PMID 37652021
  L1 83/100
• Differential Effects of Erythropoietin Administration and Overexpression on Venous Thrombosis in Mice ↗

  Thrombosis and Haemostasis · 2023 · PMID 37846465
  not yet assessed
• Multi-Omic Factor Analysis uncovers immunological signatures with pathophysiologic and clinical implications in coronary syndromes ↗

  medRxiv · 2023
  not yet assessed
• Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration ↗

  Blood · 2022 · PMID 35486845
  not yet assessed
• Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection ↗

  Nature Communications · 2022 · PMID 35197461
  not yet assessed
• Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• SpEDIT: A fast and efficient CRISPR/Cas9 method for fission yeast ↗

  Wellcome Open Research · 2020 · PMID 33313420
  not yet assessed